ClinicalTrials.gg
Sign In

Gynatresia clinical trials

The registry lists 99 studies for Gynatresia across more than 10 countries. 23 are recruiting or about to start. 77 of them are mainly about Gynatresia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03.

Get an email when these change. Save the Gynatresia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
37
Status unknown
31
Recruiting
18
Active, not recruiting
5
Not yet recruiting
4
Terminated
3

Phase

Phase 2
10
Phase 1
9
Phase 4
6
Phase 3
3
Early Phase 1
2

Where

China
44
Israel
8
United States
7
Spain
6
Egypt
4
France
4

Who runs them

Fu Xing Hospital, Capital Medical University (10) · Beijing Obstetrics and Gynecology Hospital (6) · First Affiliated Hospital, Sun Yat-Sen University (5) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (4) · Assaf-Harofeh Medical Center (4) · Sixth Affiliated Hospital, Sun Yat-sen University (3) · Fundación IVI (3) · University Hospital, Ghent (2)

What is being tested here

Drugs under test in Gynatresia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Platelet rich plasma104
Estradiol104
Dydrogesterone103
Plerixafor101
Heparin101
Hyaluronic Acid101
Granulocyte Colony-Stimulating Factor002
Menotropins001
Femoston001
Aspirin001

Coming up

0phase 3 studies under way
6studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 6

Who these studies take

Of the 18 Gynatresia studies recruiting now, 1 (6%) set no upper age limit and 17 (94%) stop at 75 or younger. 0 (0%) take children under 18. 18 (100%) are for women only and 0 (0%) for men only; 5 (28%) take healthy volunteers.

Recruiting studies that take each age, of 18
AgeWomenMen
100 (0%)0 (0%)
1813 (72%)0 (0%)
3018 (100%)0 (0%)
4017 (94%)0 (0%)
505 (28%)0 (0%)
651 (6%)0 (0%)
751 (6%)0 (0%)
851 (6%)0 (0%)

Across all 99 studies, recruiting or not: 90% stop at 75 or younger and 89% at 65; 2% take children; 100% are for women only and 0% for men only; 25% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Gynatresia studies take

Of 46 interventional studies with no phase under Gynatresia, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase23 mo14–77 · 46 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 99. Browse all 99 → or search them.